Bulgaria is set to adopt the euro on 1 January 2026, marking a major shift in its monetary regime and one that carries important implications for pharmaceutical pricing and market dynamics. Although the domestic legislative transition appears relatively straightforward — with automatic conversion rules for local...
💶 Here’s what Marketing Authorisation Holders (MAHs) need to know about medicine prices Bulgaria is officially switching to the euro on 1 January 2026. As part of this change, the prices of all medicinal products will be aligned with the new currency, in accordance with the...
Reflections from BADI’s 15th Anniversary The 15th anniversary of the Bulgarian Association for Drug Information (BADI) was more than a celebration of history. It was a forward-looking discussion about the future of regulatory affairs, the pharmaceutical industry and market access in Europe. Bringing together regulators, experts...
PharmDedict proudly represents Bulgaria & Romania in the EuDRAcon family - the European Drug Regulatory Affairs Consultants Network. EuDRAcon covers 30+ countries, including all EU member states, Norway, Switzerland, and Liechtenstein. Every member is selected based on proven regulatory expertise, reliability, and responsiveness. Founded in 2007,...
After the amendments to the Bulgarian regulation on pricing and reimbursement in December 2014, it became increasingly difficult to determine whether the government is regulating or merely registering OTC prices in Bulgaria. Under the Bulgarian Law on Medicinal Products in Human Medicine (the Drug Law), the...
Due to Brexit the European Medicines Agency (EMA) had to relocate from London to Amsterdam, which at the time created huge internal turbulences for the Agency starting with loss of staff and the additional workload to handle the Brexit. Many activities remained on hold as...
In the fast-evolving highly regulated pharmaceutical industry, staying ahead of regulatory changes, technological advancements, and market demands is а critical factor of success. At PharmDedict, we understand that agility and customization are key to meeting the unique needs of our clients. That's why we've adopted...
In the dynamic world of pharmaceuticals, regulatory affairs (RA) play a critical role in ensuring that products meet all necessary legal and safety requirements before reaching the market. However, with the complexity of regulations and the ever-changing global landscape, RA departments are facing increasing challenges....
On July 5, 2024, significant amendments to Ordinance No. H-6 were promulgated, affecting the Bulgarian National Health Information System (NHIS). These changes aim to improve access to health information and enhance personal data security. What's changing? 1. Mobile Access through "eHealth" The major innovation is the ability to...
On May 20, 2024 the Romanian Drug Agency posted an announcement about the necessity to amend the Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL) regarding the waste management of unused and/or expired medicines from the population, as follows: Annex 1 (PIL) to...